These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Immunoregulatory lymphocyte subpopulations in patients with dilated and hypertrophic cardiomyopathies]. Chumburidze VB; Iurenev AP; Tabazari DZ; Dzidziguri LM; Krukovskaia ZV Ter Arkh; 1986; 58(10):59-62. PubMed ID: 2879362 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic and functional characterization of peripheral blood mononuclear cell populations in patients with dilated cardiomyopathy. Grzelak I; Lukomska B; Sadowska-Szablisty D; Olszewski WL; Dabrowski M; Ruzyłło W Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):33-40. PubMed ID: 1839493 [TBL] [Abstract][Full Text] [Related]
8. [Changes in immunologic indices in dilated cardiomyopathy]. Amosova EN; Taradiĭ NN; Sidorova LL; Romashko VV Vrach Delo; 1988 Sep; (9):41-4. PubMed ID: 3212993 [No Abstract] [Full Text] [Related]
9. [Immunological aspects of primary cardiomyopathies]. Kardaszewicz B; Bachowska E Pol Arch Med Wewn; 1988 Apr; 79(4):213-8. PubMed ID: 3078038 [No Abstract] [Full Text] [Related]
10. [T-lymphocyte subgroup and the nature killer cell activity in cardiovascular diseases]. Xie X; Dai T Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):535-6. PubMed ID: 10073000 [No Abstract] [Full Text] [Related]
11. [Dilated cardiomyopathy. An analysis of the viral-immunological theory]. Aleksandrova LZ; Bakhov NI; Osipov SG; Naumov VG; Titov VN Ter Arkh; 1985; 57(4):136-40. PubMed ID: 2990061 [No Abstract] [Full Text] [Related]
12. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Maisch B; Deeg P; Liebau G; Kochsiek K Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861 [TBL] [Abstract][Full Text] [Related]
13. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC; Hsiao MH; Pattengale PK Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400 [TBL] [Abstract][Full Text] [Related]
14. Immune cytotoxic mechanism of myocardial lesion in non-specific myocarditis and idiopathic congestive cardiomyopathy. Zimin YuI ; Sumarokov AV; Tereshchenko SE Cor Vasa; 1988; 30(2):127-34. PubMed ID: 3391036 [TBL] [Abstract][Full Text] [Related]
19. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Seko Y; Takahashi N; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Suzuki S; Ishiwata S; Kawai S; Azuma M; Yagita H; Okumura K; Yazaki Y Circulation; 1998 Feb; 97(7):637-9. PubMed ID: 9495297 [TBL] [Abstract][Full Text] [Related]
20. Immunological study of interleukin-2 in the patients with malignant brain tumors. Yoshida S; Tanaka R; Takai N Neurol Med Chir (Tokyo); 1988 Jul; 28(7):631-4. PubMed ID: 2462167 [No Abstract] [Full Text] [Related] [Next] [New Search]